Skip to content

Drug interactions

Maraviroc + Tolvaptan

Severity: Minor

Maraviroc and Tolvaptan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tolvaptan inhibits P-glycoprotein in vitro and could modestly raise exposure to maraviroc, a P-gp substrate. The clinical relevance is uncertain and is likely small.

What this interaction means in plain words

Maraviroc and Tolvaptan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Maraviroc belongs to Anti Virals; Tolvaptan belongs to Endocrine.

Evidence level: Low

Why it happens

Tolvaptan may inhibit P-gp-mediated efflux of maraviroc, increasing its absorption and reducing its clearance.

What to do

No dose change is usually needed. Monitor for maraviroc adverse effects such as postural hypotension and hepatotoxicity.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Maraviroc and Tolvaptan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Maraviroc with Tolvaptan?

MediHelp rates the interaction as minor. Maraviroc and Tolvaptan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tolvaptan inhibits P-glycoprotein in vitro and could modestly raise exposure to maraviroc, a P-gp substrate. The clinical relevance is uncertain and is likely small.

How serious is the interaction between Maraviroc and Tolvaptan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed. Monitor for maraviroc adverse effects such as postural hypotension and hepatotoxicity.

What other medicines interact with Tolvaptan?

MediHelp also lists interactions of Tolvaptan with, for example, Atazanavir, Ceritinib, Cobicistat. The full list is on the Tolvaptan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in